Related Experiment Video
Updated: Jul 18, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Cardiovascular effects of felypressin.
Rodrigo Cecanho1, Laurival Antonio De Luca, José Ranali
1Dentistry School São Leopoldo Mandic, Campinas, Brazil. rodrigocecanho@slmandic.com.br
Felypressin (FEL) and vasopressin (AVP) cause cardiovascular effects via V1 receptors, with central V1 receptors and area postrema influencing pressor responses. FEL
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Neuroscience
Background:
- Felypressin (FEL) is a vasopressin analog with vasoconstrictive properties.
- Understanding the cardiovascular effects of FEL is crucial for its clinical application.
- The role of V1 receptors and central pathways in FEL's cardiovascular actions requires elucidation.
Purpose of the Study:
- To investigate the cardiovascular effects of felypressin (FEL) in Wistar rats.
- To determine the involvement of V1 receptors and the area postrema in FEL-induced cardiovascular responses.
- To compare the cardiovascular profile of FEL with vasopressin (AVP) and epinephrine (EPI).
Main Methods:
- Cardiovascular parameters (heart rate, mean arterial pressure) were measured in awake rats.
- Rats were treated with FEL, AVP, or EPI.
- Pharmacological interventions included intravenous (IV) and intracerebroventricular (ICV) V1 receptor antagonists, area postrema removal, and sham surgery.
- Statistical analysis employed Analysis of Variance (ANOVA) and Student-Newman-Keuls test.
Main Results:
- Both FEL and AVP induced pressor effects and bradycardia, which were inhibited by IV V1 antagonist.
- ICV V1 antagonist and area postrema removal potentiated the pressor effects of FEL and AVP.
- Epinephrine produced a greater pressor effect and similar bradycardia, unaffected by the tested interventions.
- A strong correlation between bradycardia and mean arterial pressure variation was observed for FEL, dependent on central V1 receptors and area postrema.
Conclusions:
- Felypressin mediates its pressor and bradycardic effects through V1 receptors.
- Central V1 receptors and the area postrema play a significant role in modulating FEL's cardiovascular actions.
- FEL's cardiovascular effects appear potentially less detrimental than those of epinephrine.
Related Concept Videos
Heart Failure Drugs: β-Blockers
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...

